PNA-based assay for genotyping 32 human papillomavirus types in cervical and other tissue samples for cancer risk assessment.
Manufactured by
Daejeon, South Korea
PANAGENE will always make its best efforts to develop innovative platform technologies and strive to be a global leader in the field of molecular diagnostics. We, PANAGENE Inc. have been developing and launching accurate and convenient in vitro diagnostic products consistently from Oncology to Infectious Diseases. We exercise strict quality management policy and make efforts to meet global standards and appropriate regulations for our IVD products. PANAGENE has expertise especially in cancer-related molecular diagnostics including companion diagnostics using tissue or liquid biopsy. Our advanced technology provides not only high level of detection but also simple and convenient procedure to be used easily in the front-line hospitals and clinical laboratories. (EGFR, KRAS, NRAS, BRAF, PIK3CA, IDH1, IDH2, JAK2, BCR-ABL, c-KIT, TERT, EML4-ALK, ROS1) Also we apply our platform technology to maximize multiplex capability to detect using melting curve analysis with high-level performance. (HPV, STD, CRE, TB/NTM) Lastly, we have our automation extraction system to use with molecular diagnostics kits to provide full package solution for the user. The extraction machine is 100% in house developed and optimized with our kits. During this Pandemic, we are providing the machines and extraction kits to reach out who needs the testings. (Viral, FFPE, cfDNA extraction kits) PANAGENE is pursuing open innovation and seeking opportunity for collaboration with various organizations including pharmaceutical and diagnostics companies. We always welcome organizations who are interest in our technologies and/or products. We will do our best for customer satisfaction and for realizing our vision, “Platform Technology Provider”.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
ACON Laboratories, Inc.
United States · 3 relevant products
Yaneng BIOscience (Shenzhen) Co.,Ltd.
China · 10 relevant products
Hangzhou DALTON BioSciences, Ltd.
China · 4 relevant products
Xenta Biomedical Science Co.,Ltd
China · 4 relevant products
Igenesis(Shanghai)Co.Ltd.
China · 3 relevant products
Jiangsu Macro & Micro-Test Med-Tech Co., Ltd.
China · 6 relevant products
GESIM Gesellschaft für Silizium-Mikrosysteme mbH
Germany · 1 relevant product
Introlab Belgrade
United Arab Emirates · 1 relevant product
HK UNI-MEDICA TECHNOLOGY CO.,LIMITED
China · 3 relevant products
Shenzhen Uni-medica Technology Co., Ltd
China · 2 relevant products
46 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →5 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
12 of 111 closest product alternatives
ACON Laboratories, Inc. · United States
A nucleic acid-based PCR test kit for genotyping of human papillomavirus. Provides comprehensive identification of HPV strains for clinical assessment.
Yaneng BIOscience (Shenzhen) Co.,Ltd. · China
HPV genotyping assay detecting 16, 18, 26, 31, 33, 35, 39, 45, 51, 52, 53, 56, 58, 59, 66, 68, 73, and 82 high-risk variants for comprehensive cervical cancer risk assessment.
Yaneng BIOscience (Shenzhen) Co.,Ltd. · China
Comprehensive HPV genotyping kit detecting 23 distinct human papillomavirus types including 18 high-risk and 5 low-risk strains. Enables accurate HPV infection characterization for clinical management.
Hangzhou DALTON BioSciences, Ltd. · China
Molecular assay for identifying 14 WHO-defined high-risk HPV types and 4 additional clinically relevant HPV types associated with cervical cancer. Enables comprehensive cervical cancer risk stratification.
Yaneng BIOscience (Shenzhen) Co.,Ltd. · China
HPV genotyping system for cervical cancer screening that identifies high-risk human papillomavirus types to improve diagnostic accuracy and patient risk stratification. Fully automated nucleic acid extraction and analysis platform designed for clinical laboratory integration.
Xenta Biomedical Science Co.,Ltd · China
A fluorescence PCR-based qualitative detection kit for identifying 15 types of human papillomavirus DNA from cervical or urine samples. Includes CE certification and enables specific genotype differentiation.
Igenesis(Shanghai)Co.Ltd. · China
This diagnostic kit uses real-time multiple fluorescent PCR technology combined with an Automated Fully Enclosed qPCR Instrument. It is used for in vitro qualitative detection of high-risk HPV16, HPV18, and 16 other high-risk types (HPV26, HPV31, HPV33, HPV35, HPV39, HPV45, HPV51, HPV52, HPV53, HPV56, HPV58, HPV68, HPV59, HPV66, HPV73, and HPV82) in cervical exfoliated cells or reproductive tract secretions. Test results assist in HPV auxiliary diagnosis.
Xenta Biomedical Science Co.,Ltd · China
A qualitative test kit for detecting and genotyping human papillomavirus (HPV) in cervical exfoliative cell samples using fluorescent PCR methodology. The kit is part of Xenta's molecular detection platform for HPV screening.
Jiangsu Macro & Micro-Test Med-Tech Co., Ltd. · China
A nucleic acid detection kit designed to identify 14 types of high-risk human papillomavirus (HPV) with specific genotyping for HPV types 16 and 18. This test kit enables comprehensive HPV screening and risk stratification for cervical cancer prevention. The kit provides detailed genotyping information for clinical management and patient counseling.
Xenta Biomedical Science Co.,Ltd · China
A qualitative test kit for detecting and genotyping 15 types of human papillomavirus (HPV) DNA in cervical exfoliative cells or urine samples using fluorescent PCR methodology. The kit can identify and differentiate HPV types 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, 68, and 73.
Xenta Biomedical Science Co.,Ltd · China
Qualitatively detects high-risk human papillomavirus (HPV) DNA in cervical exfoliate cells or urine samples, including types 16, 18, 26, 31, 33, 35, 39, 45, 51, 52, 53, 56, 58, 59, 66, 68, 73, and 82, with specific genotyping identification for types 16 and 18. It uses fluorescent PCR technology and has obtained CE certification.
GESIM Gesellschaft für Silizium-Mikrosysteme mbH · Germany
Microarray-based diagnostic test for detection and genotyping of human papillomavirus strains. Manufactured using precision microarray printing technology for reliable clinical detection.
99 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products